MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

FG 488 DHPE

CAS No. : 438476-80-3

MCE 站：FG 488 DHPE

产品活性：FG 488 DHPE 是一种脂质偶联荧光色素，已应用为荧光探针 Oregon Green 488。FG 488 DHPE 能够监测脂质囊泡的酸化 (λex/λem=508/534 nm)。FG 488 DHPE 也能用于 Hv1 诱导的质子转位定量 (λex/λem=508/534 nm)。

研究领域：Others

作用靶点：Others

In Vitro: FG 488 DHPE shows a pH-dependent fluorescence emission characteristic.

Monitoring acidification in Bulk vesicle assa:
1.Instrument: Jasco FP6500 spectrofluorometer, 37 ℃； fluorescence is excited at λex=508 nm ａnd the emission is detected at λem=534 nm.
2.Add 100 L proteoliposomes (cphospholipid is about 60 M) to 680 L ATPase buffer, containing the K+-ionophore valinomycin (5 nM) to enable a charge equilibration for transported protons.
3.Add ATP (1.2 mM) to induce proton pumping.
4.Add 1 mM NaN3 to ATP hydrolysis.
5.Add CCCP (carbonyl cyanide 3-chlorophenyl hydrazine, 0.4 M) to deplete the proton gradient.
6.Conversion into pH-values, fluorescence intensities are normalized to the intensity obtained directly after ATP addition.

FG 488 DHPE exerts function in quantification of pH changes induced by the voltage-dependent proton channel Hv1.

Quantification of phospholipid concentrations:
1.Add Perchloric acid (70%, 200 μL) to a sample of unilamellar vesicles containing OG488-DHPE (30 μL).
2.Heat up to 220 °C for 60 min to generate inorganic phosphate.
3.Cooling down to room temperature, add 700 μL of a solution of NH₄MoO₄ (0.45% (w/v)) ａnd perchloric acid (12.6% (w/v)) ａnd 700 μL o f a 1.7% (w/v) acetic acid solution.
4.Obtain a calibration curve to know NaH₂PO₄ concentrations.
5.Incubated samples at 80 °C for 10 min ａnd measure the absorption of the samples at 820 nm.
6.Calculate phospholipid concentrations of the vesicles using the calibration curve.

Proton translocation assay:
1.Instrument: Jasco FP6500 spectrofluorometer, 37 ℃； fluorescence is excited at λex=508 nm (3 nm band width) ａnd the emission is detected at λem=534 nm (3 nm band width).
2.Dilute proteoliposomes composed of POPC/POPG/Chol/OG488-DHPE (54.5:25:20:0.5) in buffer A in flux buffer generating a 14-fold K+-gradient across the vesicular membrane.
3.Add valinomycin (13 nM) to cause protonation of OG488-DHPE ａnd quench its fluorescence intensity in case of active Hv1 channels as described above.
4.Add CCCP (6 nM) to permeabilise all vesicles for protons.
5.The normalized fluorescence intensity Fnorm is plotted as a function of time. As a control for proton leakage, protein-free vesicles were used instead of proteoliposomes.
For the experiments in the presence of the potential inhibitor 2GBI, dissolve the inhibitor (15 mM) in flux buffer ａnd add (0.5-8.0 μL) to the proteoliposomes before addition of valinomycin to induce proton translocation.

相关产品：Antitumor agent-67  |  MeOSuc-Ala-Ala-Pro-Val-pNA  |  BDP 558/568 amine  |  ATR-IN-9  |  TBTDC  |  (S)-Norfluoxetine-d5 (phenyl-d5)  |  H-4-Pal-OH  |  (1R,2S,7R)-Sitafloxacin-d4 hydrochloride  |  6-Hydroxy-4-methylcoumarin  |  Acridine Orange base  |  CEF19, Epstein-Barr Virus latent NA-3A (458-466)  |  AC-green  |  AMT-NHS  |  Nylidrin hydrochloride  |  Naphthalene-1,2-dicarbaldehyde  |  C13-112-tri-tail  |  (4S)-1-Boc-4-fluoro-D-proline  |  D-(+)-Fucose  |  OVA Peptide 323-339  |  Secretin (swine)  |  Bletilloside A  |  Transcriptional Intermediary Factor 2 (TIF2) (740-753)  |  RPR132595A-phenylmethyl hydrogen carbonate-d3  |  Fmoc-Ser(tBu)-OH-13C3,15N  |  Pep-1 (uncapped)  |  Aspochalasin M  |  Dihydrofuran-3(2H)-one  |  Rhodamine 800  |  (S)-Tamsulosin-d3 hydrochloride  |  BPK-29 hydrochloride

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  染料试剂  |  PROTAC  |  同位素标记物  |  寡核苷酸

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds  |  Oligonucleotides

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。